Post herpetic neuralgia, schwann cell activation and vitamin D

Medical Hypotheses

Volumn 73, Issue 6, 2009, Pages 927-929

  Bartley, Jim ^a  

^a FRACS   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; EMLA; GABAPENTIN; IBUDILAST; INTERLEUKIN 10; LIDOCAINE; MINOCYCLINE; NALOXONE; NALTREXONE; NEUROLEPTIC AGENT; NITRIC OXIDE; OPIATE; PENTOXIFYLLINE; PREGABALIN; PROPENTOFYLLINE; PSYCHOTROPIC AGENT; RECOMBINANT NERVE GROWTH FACTOR; SUBSTANCE P; TRICYCLIC ANTIDEPRESSANT AGENT; VITAMIN D;

ARTICLE; ATROPHY; CELL ACTIVATION; CLINICAL FEATURE; CLINICAL TRIAL; DIABETIC NEUROPATHY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MECHANISM; DRUG MEGADOSE; HERPES ZOSTER; HUMAN; INFECTION; NERVE CELL EXCITABILITY; NONHUMAN; PATHOPHYSIOLOGY; PERIPHERAL NERVOUS SYSTEM; PHOTOTHERAPY; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; PROTEIN SECRETION; SCHWANN CELL; SKIN BURNING SENSATION; SKIN NERVE; SPINAL CORD DORSAL HORN; SUN EXPOSURE; ULTRAVIOLET B RADIATION; VITAMIN INTAKE;

HUMANS; NEURALGIA, POSTHERPETIC; SCHWANN CELLS; VITAMIN D;

HERPES ZOSTER;

EID: 70449709251     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.06.039     Document Type: Article

References (41)

1. Maiha, H. Zoster-associated pain and nociceptors. In Basbaum AI, Bushnell MC, editors. Science of Pain. Oxford: Elsevier; 2009, p. 75-81.
2. Head H., and Campbell A.W. The pathology of herpes zoster and its bearing on sensory localization. Brain 23 (1900) 353-523
3. Oaklander A.L. The density of remaining nerve endings in human skin with and without postherpetic neuralgia after shingles. Pain 92 (2001) 139-145
4. Oaklander A.L. Mechanisms of pain and itch caused by Herpes Zoster (Shingles). J Pain 9 (2008) S10-S18
5. Portenoy R.K., Duma C., and Foley K.M. Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann Neurol 20 (1986) 651-664
6. Nurmikko T., and Bowsher D. Somatosensory findings in postherpetic neuralgia. J Neurol Neurosurg Psychiatry 53 (1990) 135-141
7. Watson C.P.N., Deck J.H., Morshead C., et al. Post-herpetic neuralgia: further post-mortem studies of cases with and without pain. Pain 44 (1991) 105-117
8. Baron R., and Sauger M. Post herpetic neuralgia: are C-nociceptors involved in signalling and maintenance of tactile allodynia?. Brain 116 (1993) 1477-1496
9. Zacks S.L., Langfitt T.W., and Elliott F.A. Herpetic neuritis: a light and electron microscopic study. Neurology 14 (1964) 744-750
10. Watson C.P.N., Morshead C., Van der Kooy D., et al. Post herpetic neuralgia: post-mortem analysis of a case. Pain 34 (1988) 129-138
11. Rowbotham M.C., and Fields H.L. The relationship of pain, allodynia and thermal sensation in post-herpetic neuralgia. Brain 119 (1996) 347-354
12. Pappagallo M., Oaklander A., Quatrano-Placentini A., et al. Heterogenous patterns of sensory dysfunction in postherpetic neuralgia. Pain 88 (2000) 125-133
13. Oaklander A.L., Romans K., Horasek S., Stocks A., Hauer P., and Meyer R.A. Unilateral postherpetic neuralgia is associated with bilateral sensory neuron damage. Ann Neurol 44 (1998) 789-795
14. Helgason S., Petursson G., Gudmundsson S., and Sigurdsson J.A. Prevalence of postherpetic neuralgia after the first episode of herpes zoster: prospective study with long term follow up. BMJ 321 (2000) 794-796
15. Scott F.T., Leedham-Green M.E., Barnett-Muir W.Y., et al. A study of shingles and the development of post herpetic neuralgia in East London. J Med Virol 70 Suppl 1 (2003) S24-S30
16. Watkins L.R., Milligan E.D., and Maier S.F. Glial activation: a driving force for pathological pain. Trends Neurosci 24 (2001) 450-455
17. Sorkin LA, Schafers M. Immune cells in peripheral nerve. In: De Leo JA, Sorkin LA, Watkins LR, editors. Immune and glial regulation of pain. Seattle: IASP Press; 2007. p. 1-19.
18. Bergsteinsdottir K, Kingston A, Mirky R, Jessen KR. Rat schwann cells produce interleukin-1. J Neuroimmunol 1991;34:15-23.
19. Bolin LM, Verity AN, Silver JE et al. Interleukin 6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem 1995;64:850-8.
20. Myers R.R., Campana W.M., and Shubayev V.I. The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. Drug Discov Today 11 (2006) 8-20
21. Hanani M. Satellite glial cells in sensory ganglia: from form to function. Brain Res Brain Res Rev 48 (2005) 457-476
22. Devor M., Govrin-Lippman R., and Angelides K. Na+ channel immunolocalization in peripheral mammalian axons and changes following nerve injury and neuroma formation. J Neurosci 13 (1993) 1976-1992
23. Rutkowski J.L., Tuite G.F., Lincoln P.M., Boyer P.J., Tennekoon G.I., and Kunkel S.L. Signals for proinflammatory cytokine secretion by human Schwann cells. J Neuroimmunol 101 (1999) 47-60
24. Xu J.T., Xin W.J., Zang Y., Wu C.Y., and Liu X.G. The role of tumor necrosis factor-alpha in the neuropathic pain induced by Lumbar 5 ventral root transection in rat. Pain 123 (2006) 306-321
25. Sauer S.K., Bove G.M., Averbeck B., and Reeh P.W. Rat peripheral nerve components release calcitonin gene-related peptide and prostaglandin E2 in response to noxious stimuli: evidence that nervi nervorum are nociceptors. Neuroscience 92 (1999) 319-325
26. Zochodne D.W. Local events within the injured and regenerating peripheral nerve trunk: the role of the microenvironment and microcirculation. Biomed Rev 8 (1997) 37-54
27. Bove G.M. Epi-perineurial anatomy, innervation, and axonal nociceptive mechanisms. J Bodyw Mov Ther 12 (2008) 185-190
28. Wu CL, Raja SN. An update on the treatment of postherpetic neuralgia. J Pain 2008;9:S19-30.
29. Dworkin RH. Recent advances in reducing the burden of herpes zoster and postherpetic neuralgia. J Pain 2008;9:S1-2.
30. Rains C., and Bryson H.M. Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post herpetic neuralgia, diabetic neuropathy, and osteoarthritis. Drugs Aging 7 (1995) 317-328
31. De Benedittis G., and Lorenzetti A. Topical aspirin/diethyl ether mixture versus indomethacin and diclofenac/diethyl ether mixtures for acute herpetic neuralgia and postherpetic neuralgia: a double-blind crossover placebo-controlled study. Pain 65 (1996) 45-51
32. King R.B. Topical aspirin in chloroform and the relief of pain due to herpes zoster and postherpetic neuralgia. Arch Neurol 50 (1993) 1046-1053
33. Seiffert K., and Granstein R.D. Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression. Methods 28 (2002) 97-103
34. Brzoka T., Luger T.A., Maaser C., et al. Alpha-melanocyte-stimulating hormone and related tripeptides: biochemistry, antiinflammatory and protective effects in vitro and in vivo, and future perspectives for the treatment of immune-mediated inflammatory diseases. Endocr Rev 29 (2008) 581-602
35. Kiraly S.J., Kiraly M.A., Hawe R.D., and Makhani N. Vitamin D as a neuroactive substance. Scientific World J 6 (2006) 125-139
36. Clacutt N.A., Jolivant C.G., and Fernyhough P. Growth factors as therapeutics for diabetic neuropathy. Current Drug Targets 9 (2008) 47-59
37. Leinninger G.M., Vincent A.M., and Feldman E.L. The role of growth factors in diabetic peripheral neuropathy. J Peripher Nerv Syst 9 (2004) 26-53
38. Lee P., and Chen R. Vitamin D as an analgesic for patients with Type II diabetes and neuropathic pain. Arch Intern Med 168 (2008) 771-772
39. Hutchinson M.R., Bland S.T., Johnson K.W., et al. Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward. Scientific World J 7 (2007) 98-111
40. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations and safety. Am J Clin Nutr 69 (1999) 842-856
41. Manning DC. Immunomodulatory therapies for complex regional pain syndrome: thalidomide and beyond. In: De Leo JA, Sorkin LA, Watkins LR, editors. Immune and glial regulation of pain. Seattle: IASP Press; 2007. 407-16.